close
close

The in vitro diagnostic device market is expected to grow by 7.5%

Danetelo

Danetelo

According to the latest report published by Dataintelo, the global in vitro diagnostic devices market will witness extraordinary growth, growing at a compound annual growth rate (CAGR) of 7.5% during 2022-2030. This anticipated market expansion is attributed to the rising prevalence of chronic diseases, growing demand for point-of-care testing, and continuous technological advancements in the sector.

It is worth noting that the dominant position is occupied by biochemical analyzers, which had the largest market share in 2017. This segment is expected to maintain its dominance and grow at a CAGR of 7.8% over the forecast period of 2022-2030. These devices measure the concentration of certain metabolites, enzymes, proteins and electrolytes in samples of serum, plasma, urine, cerebrospinal fluid and other body fluids, and have become key tools in the diagnosis and treatment of many diseases.

Growing global health crises characterized by chronic diseases are emerging as a significant driver for the in vitro diagnostic devices market. Factors such as an aging population, lifestyle changes, unhealthy eating habits and physical inactivity contribute to the increase in the incidence of chronic diseases such as heart disease, cancer, diabetes and respiratory diseases, necessitating early and effective diagnosis.

The market progress is also supported by the growing demand for point-of-care tests. This can largely be attributed to its advantages such as quick turnaround time, high sensitivity, and ease of use that allows testing to be performed outside traditional laboratory settings.

This growth is also complemented by continuous technological progress in the field of in vitro diagnostic devices. High-throughput laboratory automation, miniaturization, integration, nanotechnology and the convergence of systems, materials and applications are creating breakthrough opportunities and catalyzing market development.

The Dataintelo report provides a comprehensive analysis covering key areas such as market dynamics, segmentation, regional analysis and competitive landscape. The study reveals in detail the current market trends, opportunities, challenges, growth drivers and restraints, providing valuable insights to stakeholders, service providers and investors in the In Vitro Diagnostic Devices market

@ https://datataintelo.com/request-sample/267828

๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐จ๐ง๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฆ๐จ๐ฌ๐ญ ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ง๐ ๐œ๐จ๐ฏ๐ž๐ซ ๐œ๐จ๐ฏ๐ž๐ซ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ:

The in vitro diagnostic devices market has been segmented based on๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐“๐ฒ๐ฉ๐ž
โ— Biochemical analyzers
โ— Urine analyzers
โ— Immunoassay analyzers
โ— Coagulation analyzers
โ— Hematology analyzers
โ— Microbiological analyzers
โ— Other

๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ
โ— Immunochemistry
โ— Clinical chemistry
โ— Molecular diagnostics
โ— Microbiology
โ— Hematology
โ— Coagulation and hemostasis
โ— Other

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง
โ— Hospitals
โ— Laboratories
โ— Clinics
โ— Bedside testing
โ— Patient self-monitoring
โ— Other

๐„๐ง๐ ๐”๐ฌ๐ž๐ซ
โ— Hospitals
โ— Laboratories
โ— Home care
โ— Other

๐‘๐ž๐ ๐ข๐จ๐ง
โ— Asia Pacific
โ— North America
โ— Latin America
โ— Europe
โ— Middle East and Africa

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ
โ— Roche
โ— Siemens
โ— Abbot
โ— Beckman
โ— BD
โ— Johnson & Johnson
โ— BioMerieux
โ— Bio-Rad
โ— Sysmex
โ— Thermo Fisher Scientific
โ— Roche
โ— Grifoles
โ— Hitachi
โ— Toshiba
โ— Erba Mannheim
โ— KHB

Segment analysis:

The in vitro diagnostic products market has been divided into segments depending on the type of product. Some of the key types include biochemistry analyzers, urinalysis analyzers, immunoassay analyzers, hematology analyzers, coagulation analyzers, microbiology analyzers and others. The market was also distinguished based on technologies, including: immunochemistry, clinical chemistry, microbiology, molecular diagnostics, hematological diagnostics, coagulation and hemostasis. The use of these devices covers various areas such as hospitals, laboratories, clinics, point-of-care testing, patient self-testing. Among them, the devices are most widely used in hospitals and laboratories. End users in this market include hospitals, laboratories and home care.

Regional analysis:

Regionally, the in vitro diagnostic devices market is segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. This market has a significant presence in North America and Europe due to the high prevalence of diseases and the increasing use of advanced diagnostic techniques. However, the Asia-Pacific region is expected to experience significant growth due to increasing awareness of diseases and rising health care expenses. The major key players in this market include Roche, Siemens, Abbott, Beckman, BD, Johnson & Johnson, BioMerieux, Bio-Rad, Sysmex, Thermo Fisher Scientific, Grifols, Hitachi, Toshiba, Erba Mannheim and KHB. These players are contributing significantly to the market growth and continue to shape the landscape with their advanced product portfolio

@ https://datataintelo.com/request-sample/267828

Market factors for the in vitro diagnostic devices market:

1. Increasing incidence of chronic and infectious diseases: The increase in diseases such as cancer, cardiovascular diseases, diabetes, HIV/AIDS and other infectious diseases is driving the need for diagnostic devices to improve treatment of patients.

2. Technological advancements: Continuous improvements and technological advancements in diagnostic devices, including automation and miniaturization, are driving the demand for these products.

3. Growing Elderly and Obese Population: As the elderly and obese population continues to grow, the need for chronic disease monitoring and preventive care increases.

4. Increase in the number of private diagnostic centers: An increasing number of private diagnostic centers offering fast and accurate results are increasing the use of in vitro diagnostic facilities.

5. Strong preference for point-of-care (POC) tests: There is a growing preference for point-of-care diagnostics due to their ability to provide immediate results, which helps in better disease management and prognosis.

Opportunities for the in vitro diagnostic devices market:

1. Emerging markets: Developed countries are characterized by high market penetration of in vitro diagnostic products. However, in developing countries the scenario is completely opposite and offers potential growth opportunities.

2. Companion Diagnostics: The development and adoption of companion diagnostics creates an opportunity for growth in the market. These tests are designed to assess whether a patient will respond to a specific treatment protocol, thereby improving treatment success rates.

3. Precision medicine: The growing use of precision medicine, which focuses on identifying personal genetic profiles and prescription treatments, may provide opportunities for growth.

4. Investment in research and development: Greater emphasis on research and development activities to introduce innovative products will provide significant opportunities for market participants.

5. Direct-to-Consumer (DTC) Diagnostic Testing: The emergence of DTC testing, which provides consumers with information about their genetic predisposition to certain health conditions, creates potential growth opportunities for the market

๐˜๐จ๐ฎ ๐œ๐š๐ง ๐๐ข๐ซ๐ž๐œ๐ญ๐ฅ๐ฒ ๐›๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐ซ ๐จ๐ฆ: https://datataintelo.com/checkout/267828

This report should be purchased by enterprises, entrepreneurs, market researchers, analysts, business strategists and investors who want to understand current market trends, future market potential, customer preferences, competitive landscape and various other factors that may influence their business decisions and strategies.

Some good things about Dataintelo:

1. Comprehensive Analysis: Dataintelo offers comprehensive and accurate industry reports that provide detailed market analysis including growth opportunities, trends, threats, competitive spectrum and application prospects.

2. Expert Insights: The team of experts uses various methodologies and tools to collect, compile and analyze data, offering insightful and reliable market forecasts.

3. Custom Reports: Provides customized market reports based on specific business requirements, ensuring relevance and usability.

4. Up-to-date information: Dataintelo ensures that its reports are constantly updated, providing the most relevant and up-to-date information on the market.

5. Broad Spectrum: Cover a broad spectrum of industries such as technology, healthcare, chemicals, food and beverage, consumer goods, materials science and automotive, helping companies in any sector benefit from their reports.

6. Excellent Customer Service: Their team provides excellent customer service – they are always ready to help with any questions or problems their customers may have.

7. Affordable Pricing: Dataintelo offers various pricing plans for market research reports, making them more accessible to businesses of all sizes

Contact us :
Danetelo
Name: Alex Matthews
Tel: +1 909 414 1393
E-mail – [email protected]
Website – https://datataintelo.com
Address โ€“ 500 East E Street, Ontario, CA 91764, United States.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐œ๐š๐ง ๐›๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ž๐ ๐š๐ฌ ๐ฉ๐ž๐ซ ๐ฒ๐จ๐ฎ ๐ซ ๐ง๐ž๐ž๐.

๐„๐ฆ๐š๐ข๐ฅ ๐ฎ๐ฌ ๐จ๐ง – ๐ฌ๐š๐ฅ๐ž๐ฌ@๐๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ.๐œ๐จ๐ฆ

๐€๐›๐จ๐ฎ๐ญ ๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ:

๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ has extensive experience in creating tailored market research reports in various industries. With in-depth market analysis, creative business strategies for new entrants and insight into the current market scenario, our reports are subjected to intensive primary and secondary research, interviews and consumer surveys.

This release was published on openPR.